All Stories

  1. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1
  2. Knockout of Epstein-Barr Virus BPLF1 Retards B-Cell Transformation and Lymphoma Formation in Humanized Mice
  3. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1
  4. The Rad6/18 Ubiquitin Complex Interacts with the Epstein-Barr Virus Deubiquitinating Enzyme, BPLF1, and Contributes to Virus Infectivity
  5. Maribavir Inhibits Epstein-Barr Virus Transcription through the EBV Protein Kinase
  6. Epstein-Barr Virus BPLF1 Deubiquitinates PCNA and Attenuates Polymerase   Recruitment to DNA Damage Sites
  7. Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9
  8. Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication
  9. The Epstein-Barr Virus (EBV) Deubiquitinating Enzyme BPLF1 Reduces EBV Ribonucleotide Reductase Activity
  10. Location and Role of Free Cysteinyl Residues in the Sindbis Virus E1 and E2 Glycoproteins
  11. Single and multiple deletions in the transmembrane domain of the Sindbis virus E2 glycoprotein identify a region critical for normal virus growth